BridgeMD
Compares treatment options for Soft Tissue Augmentation at Dental Implants
Official title Assessment of Soft Tissue Thickness Following Utilization of Buccal Pad of Fat Versus Platelet-rich Fibrin for Covering Zygomatic Implants: A Randomized Clinical Trial
ClinicalTrials.gov ID: NCT07562334
What this study is testing
What is Coverage with PRF for Zygomatic implant placed?
Coverage with PRF for Zygomatic implant placed is an investigational medicine, being studied as a potential treatment for soft tissue augmentation at dental implants.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Would buccal pad of fat be comparable to platelet rich fibrin for Zygomatic implant coverage as a step for reconstruction of atrophic posterior maxilla, in terms of peri-implant soft tissue thickness and avoiding complicated postoperative sequalae?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients with severely atrophic edentulous upper arch (Cawood class IV, V, VI) that could not be restored by other type of treatment
- Patients who had at least 8-12 mm vertical bone height in anterior maxilla to allow installation of 2 conventional implants.
- Lacking posterior maxillary bone support due to significant sinus pneumatization
- Good systemic health (ASA score I-II)
- Highly motivated patients
You likely can't join if
- Patient not willing to give his/her informed consent.
- Patients with systemic disease that did not permit the surgical procedure (including general anesthesia).
- Patients with uncontrolled diabetes or under bisphosphonate therapy.
- Heavy smoker. (\> 20 cigarettes daily)
- Patient with psychiatric problems, severe bruxism or other parafunctional habits.
- Acute sinusitis.
See the full eligibility criteria
- Patients with severely atrophic edentulous upper arch (Cawood class IV, V, VI) that could not be restored by other type of treatment
- Patients who had at least 8-12 mm vertical bone height in anterior maxilla to allow installation of 2 conventional implants.
- Lacking posterior maxillary bone support due to significant sinus pneumatization
- Good systemic health (ASA score I-II)
- Highly motivated patients
- Patient not willing to give his/her informed consent.
- Patients with systemic disease that did not permit the surgical procedure (including general anesthesia).
- Patients with uncontrolled diabetes or under bisphosphonate therapy.
- Heavy smoker. (\> 20 cigarettes daily)
- Patient with psychiatric problems, severe bruxism or other parafunctional habits.
- Acute sinusitis.
- Malignancy or pathology in Maxilla or Zygoma.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Cairo Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Cairo Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.